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Background: In thyroid cancer, preoperative ultrasonography (US) is performed to detect the primary tumor and
lymph node metastasis (LNM), which are related to prognosis. This study examined the relationships between
specific US findings and LNM in micropapillary thyroid cancer (MPTC).
Methods: Data on 220 patients with solitary MPTC who underwent total thyroidectomy and neck dissection
between 2008 and 2009 were evaluated retrospectively. We classified the US findings according to the nature,
shape, echogenicity, extent, margin, and calcification of the primary tumor and evaluated the correlations between
these findings and those of LNM.
Results: Hypoechogenicity (odds ratio = 2.331, P = 0.025) and marked hypoechogenicity (OR = 4.032, P = 0.016) of
MPTC were risk factors for central LNM. All of the patients with lateral cervical LNM showed hypoechogenicity or
marked hypoechogenicity. Hypoechogenicity (odds ratio = 5.349, P = 0.047) and other types of calcification (odds
ratio = 2.495, P = 0.010) were significant risk factors for lateral cervical LNM.
Conclusions: Specific sonographic findings (hypoechogenicity or marked hypoechogenicity, and calcification)
suggest LNM.
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Various clinical factors are related to lymph node metas-
tasis (LNM) of papillary thyroid cancer (PTC), including
tumor size and extrathyroidal extension. The reported
LNM rate of PTC is 20 to 50% [1], and a 90% microme-
tastasis rate was reported depending upon the detection
method [2]. The locoregional recurrence rate of PTC
ranges from 5 to 20%, and most recurrences involve
lymph nodes [3]. Although micropapillary thyroid cancer
(MPTC) usually has a much better prognosis than thyroid
cancer of more than 1 cm, LNM is relatively common [4].
The central lymph node metastasis (CLNM) rate and lat-
eral cervical lymph node metastasis (LCLNM) rate in
MPTC ranges from 13 to 43% and 3 to 44.5%, respectively
[5-8]. Some clinicopathological characteristics of MPTC* Correspondence: voicelee@pusan.ac.kr
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unless otherwise stated.have been reported to predict aggressive tumor behavior,
such as LNM, and some of them have been used as guide-
lines for surgical extent and adjuvant radioactive iodine
therapy [9]. Despite the controversy over the prognostic
role of CLNM, LCLNM is a significant predictor of recur-
rence and distant metastasis [10,11]. However, the prog-
nostic value of LCLNM is still unclear, mainly due to the
slow progression of metastatic lymph nodes and difficulty
proving a survival benefit after neck dissection. Thera-
peutic neck dissection is indicated for definite metastasis
in the lateral compartment to reduce the recurrence rate,
whereas prophylactic lateral cervical lymph node dissec-
tion fails to result in recurrence-free survival and is not
usually performed [9].
Preoperative diagnosis of LCLNM determines the treat-
ment strategy, and optimum therapy will improve treat-
ment outcome. Tumor size, extrathyroidal extension, and
the number of CLNMs are known predictors of LCLNM
in MPTC [11-13]. However, most of these histological. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Echogenicity of thyroid cancer (arrow). (A) Isoechoic
nodule on the posterior aspect of the right thyroid gland. The
nodule has similar echogenicity to the thyroid gland. (B)
Hypoechoic nodule on the medial aspect of the left thyroid gland.
The nodule has hypoechoic echogenicity compared to the thyroid
gland. (C) Markedly hypoechoic nodule of the left thyroid gland. The
nodule has more hypoechoic echogenicity than that of strap
muscle.
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operative evaluation is required.
Ultrasonography (US) is widely used in preoperative or
follow-up examinations to detect primary and metastatic
tumors in PTC and provides critical information on sur-
gical extent [14-16]. US investigations may detect local
recurrences at an early stage and can precede either an
elevated serum stimulated thyroglobulin level or positive
findings on whole-body iodine scans [17]. In addition to
diagnostic accuracy, US has the benefit of being a non-
invasive, relatively simple procedure, which can be com-
bined with fine needle aspiration (FNA). Recent studies
have suggested that some sonographic findings of the
primary tumor in PTC are negative prognostic indica-
tors, such as extrathyroidal extension or CLNM [18].
Based on these ideas, this study examined US findings of
LNM in MPTC by analyzing the correlations between




Between January 2008 and November 2009, 389 patients
were diagnosed with PTC and underwent a total thyroid-
ectomy and routine bilateral central lymph node dissec-
tion with or without LNM. Medical charts were reviewed
after approval by the institutional review board. The clin-
ical variables collected included age, gender, pathological
findings, and US findings. Pathological findings included
tumor size, extrathyroidal extension, and LNM (CLNM
and/or LCLNM). Patients with solitary MPTC and pre-
operative US reports were included, whereas all patients
with recurrent or multiple PTC or tumors larger than
1 cm were excluded. Central lymph nodes and lateral cer-
vical lymph nodes were classified according to the TNM
classification established by the International Union
Against Cancer and the American Joint Commission on
Cancer (2010 AJCC Seventh Edition) [19].
Imaging
Three experienced endocrinologists performed and
reviewed preoperative US examinations of the neck. US
findings were documented according to the criteria dis-
criminating malignant from benign thyroid nodules [14].
LNM was confirmed by a pathologist postoperatively.
The US examination was performed using a Vivid i US
scanner (GE Healthcare, Milwaukee, WI, USA) using
electronically focused linear probes with a bandwidth of
10 to 13 MHz [14]. US findings of the tumors were classi-
fied according to the nature (solid/mixed), shape (round to
ovoid/irregular/taller than wide), echogenicity (isoechoic/
hypoechoic/markedly hypoechoic; Figure 1), margin
(well defined/poorly defined), calcification (no calcification/
microcalcification/other types of calcification; Figure 2),and vascularity of the primary tumor. The sonographic
size of the primary tumor was measured. Markedly hypoe-
choic echogenicity was described when echogenicity of
the primary tumor was lower than the that of surrounding
strap muscle [14]. Other types of calcification included
macrocalcification and fine stippled psammomatous calci-
fication (nodular, piece-like, rim-like, and irregular shape)
Figure 2 Calcification of thyroid cancer (arrow). (A) Microcalcification.
(B) Other types of calcification. (C) Macrocalcification in other types
of calcification.
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of the rates of CLNM and LCLNM. Vascularity was ex-
cluded in this study because it was not consistent and was
not recorded routinely.Surgery
Enrolled patients underwent a total thyroidectomy and
routine bilateral central lymph node dissection. Central
lymph node dissection involved all soft tissues contain-
ing lymph nodes, from the hyoid bone superiorly to the
innominate artery inferiorly and the common carotid ar-
tery laterally [21]. Level II to IV lateral cervical lymph node
dissection was performed when US-guided FNA confirmed
LNM or when preoperative high-resolution US or neck
computed tomography showed suspicious findings. Suspi-
cious findings on US or computed tomography included
LCLNM of enlarged size, cystic changes, round shape, ec-
centric cortical widening, decreased echogenicity, loss of
fatty hilum, presence of calcification, and increased intra-
nodal vascularity [22]. A minor axis greater than 50% of
the major axis, minor axis greater than 10 mm, or hypere-
chogenicity with or without microcalcifications were also
considered suspicious findings for LNM in PTC [23].
Statistics
The statistical analyses were performed using SPSS ver-
sion 15.0 (Chicago, IL, USA). Fisher’s exact test was used
to analyze the relationship between the rate of LNM and
the US findings. After validating significant US findings,
multiple logistic regression analysis was used to identify
US findings related to LNM with significant odds ratios.
All reported P-values are two-sided.
Results
Of the patients enrolled in this study, 220 of 389 (56.6%)
had solitary MPTC and 81.1% of these (n = 194) were fe-
male. The mean age was 48.4 ± 10.64 years. CLNM and
LCLNM were confirmed in 41.4% (n = 91) and 6.4% (n =
14), respectively. One skip metastasis, defined as LCLNM
without CLNM, was observed in this population. The US
characteristics are reported in Table 1. Most of the pri-
mary tumors were solid (99.5%), hypoechoic (90.9%), with
poorly defined margin (73.2%) and absent calcification
(74.1%). Irregular, round to ovoid, and taller than wide
shape were almost evenly distributed.
First, the relationship between the US findings of the
primary tumor and the rate of LNM was analyzed
(Table 2). In the univariate analyses, solid nature and
calcification did not increase the rate of LNM. The pri-
mary tumors that were irregular or taller than wide
shape showed higher rates of LNM than those that were
round to ovoid. A poorly defined margin was signifi-
cantly related to LNM. We performed multivariate ana-
lysis using significant factors from the univariate analysis
to reveal the factors predisposing to LNM. Hypoechoic
(odds ratio = 2.331, 95% CI 0.073 to 8.839; P = 0.025)
and markedly hypoechoic (odds ratio = 4.032, 95% CI
0.216 to 16.852; P = 0.016) lesions increased the risk of
LNM, as compared to isoechoic lesions (Table 3).
Table 1 Patient distribution according to the
ultrasonography findings of the primary tumor
Ultrasonography findings n (%)
Nature Solid 219 (99.5)
Mixed 1 (0.5)
Shape Round to ovoid 83 (37.7)
Irregular 81 (36.8)
Taller than wide 56 (25.5)
Echogenicity Isoechoic 20 (9.1)
Hypoechoic 80 (36.4)
Markedly hypoechoic 120 (54.5)
Margin Well defined 59 (26.8)
Poorly defined 161 (73.2)
Calcification Absent 163 (74.1)
Microcalcification 29 (13.2)
Other types 28 (12.7)
Table 3 Multivariate analysis presenting correlation
between ultrasonography findings of the primary tumor
and cervical lymph node metastasis in micropapillary
thyroid cancer
B SE P value Exp(B) 95% CI
Lower Upper
Shape 0.364
Irregular -0.465 0.441 0.292 1.592 0.264 1.492
Taller than wide -0.509 0.371 0.170 1.663 0.290 1.245
Echo 0.014
Hypoechoic -1.393 0.621 0.025 2.331 0.073 8.839
Markedly hypoechoic -0.847 0.350 0.016 4.032 0.216 16.852
Margin 0.095 0.415 0.820 1.099 0.487 2.481
Constant 0.250 0.855 0.770 1.284
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findings of microPTC and the rate of LCLNM. LCLNM
was found in 14 patients (6.4%). Gender and age were
not related to LCLNM. Although all of the tumors with
LCLNM were solid, the nature and margin were not sig-
nificant factors affecting LCLNM in the univariate analysis
(Table 4). Instead, taller than wide shape seemed to be
related to LCLNM (P = 0.088), but the rate of LCLNM
was not significantly higher than that for either round
to ovoid or irregular masses. The primary tumors with
LCLNM were all hypoechoic and the rate of LCLNM wasTable 2 Univariate analysis of the correlation between
ultrasonography findings of the primary tumor and rate
of cervical lymph node metastasis in micropapillary
thyroid cancer
Ultrasonography findings n (rate of lymph
node metastasis, %)
P value
Nature Solid 91 (41.6) 0.400
Mixed 0 (0)
Shape Round to ovoid 27 (32.5) 0.014
Irregular 32 (39.5)
Taller than wide 32 (57.1)
Echogenicity Isoechoic 4 (20.0) <0.001
Hypoechoic 23 (28.7)
Markedly hypoechoic 64 (53.3)
Margin Well defined 18 (30.5) 0.033
Poorly defined 73 (45.3)
Calcification Absent 65 (39.9) 0.745
Microcalcification 13 (44.8)
Other types 13 (46.4)higher in “markedly hypoechoic” tumors (10.0%) than just
“hypoechoic’ tumors” (2.5%, P = 0.049). Of the tumors
with LCLNM, 92.9% (n = 13) had poorly defined margins,
but this was not significantly (P = 0.071) related to the rate
of LCLNM. Other types of calcified lesions in the primary
tumor were related to the rate of LCLNM (P = 0.027).
After the univariate analysis, multivariate analysis was per-
formed using the relevant factors, shape, echogenicity,
margin, and calcification (Table 5). Isoechoic lesions were
not seen in tumors with LCLNM and the rate of LCLNM
was compared between markedly hypoechoic and hypoe-
choic lesions. In the multivariate analysis, marked hypoe-
chogenicity (odds ratio = 5.349, 95% CI 1.025 to 27.915;
P = 0.047) and other calcified lesions (odds ratio = 2.495,
95% CI 1.246 to 4.995; P = 0.010) were significant risk fac-
tors for LCLNM. The mean size of the tumors with
LCLNM (0.71 ± 0.18 cm) was greater than that of the tu-
mors with (0.68 ± 0.18 cm) or without (0.66 ± 0.17 cm)
CLNM, but the difference was not significant.
Discussion
Lymph node metastasis is one of the factors determining
the extent of surgery and use of adjuvant radioactive
iodine therapy. This study examined whether the US
findings are related to an aggressive pattern of MPTC,
such as extrathyroidal extension and LNM. Reported
risk factors for LNM include extrathyroidal extension,
tumor size, multifocality, and the number of CLNM
[11,13,24]. All tumors with LCLNM were solid, while
most tumors with LCLNM were also solid. Because most
of the enrolled tumors were solid in nature, solidity was
not a predicting factor for LCLNM, which was shown in
the statistical analysis. Hypoechoic or markedly hypoechoic
lesions on US were related to LNM and to LCLNM in this
study. Other types of calcifications, except microcalcifica-
tion, are other risk factors for LCLNM, which is in contrast
to the finding that microcalcification is suggestive of PTC.
Table 4 Univariate analysis of correlation between
ultrasonography findings of the primary tumor and rate
of lateral cervical lymph node metastasis in
micropapillary thyroid cancer
Ultrasonography findings n (rate of lateral cervical
lymph node metastasis, %)
P value
Nature Solid 14 (6.39) 0.794
Mixed 0 (0)
Shape Round to ovoid 3 (3.61) 0.088
Irregular 4 (4.94)
Taller than wide 7 (12.5)





Margin Well defined 1 (1.69) 0.071
Poorly defined 13 (8.07)
Calcification Absent 8 (4.9) 0.027
Microcalcification 1 (3.4)
Other types 5 (6.4)
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rates exceeding 90%, locoregional recurrences are not in-
frequent. LNM at the initial surgery predisposes to re-
currence [8,11,25], and postoperative adjuvant therapy,
including thyroid stimulating hormone suppression ther-
apy and radioactive iodine therapy, reduces the recur-
rence rate [9]. However, the results reported in the
literature are sometimes inconsistent and even conflict-
ing, which is due to the lack of stratification of each risk
factor. Although a recent series of studies showed that
the presence of nodal metastasis is related to survival
[26], the influence of LNM on treatment outcome is lim-
ited in the low-risk group, especially in MPTC. CLNM is
one of the risk factors for LCLNM and it is unlikely that
it affects the distant metastasis and survival rates by it-
self. Additional factors have been suggested, such as the
number of lymph nodes, extranodal spread and nodeTable 5 Multivariate analysis presenting correlation
between ultrasonography findings of the primary tumor




B SE P value Exp (β) 95% CI
Lower Upper
Shape 0.158 0.448 0.724 1.172 0.487 2.819
Echogenicity 1.677 0.843 0.047 5.349 1.025 27.915
Margin 0.560 1.133 0.621 1.751 0.190 16.128
Calcification 0.914 0.354 0.010 2.495 1.246 4.995
Constant -9.966 2.833 0.000 0.0001size [27]. While the number of lymph nodes removed at
neck dissection is not related to the recurrence rate of
PTC [28], LCLNM affects the prognosis in proportion to
the primary tumor size [29]. Lateral neck extension is
thought to be associated with high rates of recurrence
and distant metastasis in MPTC [11,30,31]. Radioactive
iodine therapy has a limited role in eradicating evident
metastasis, where surgical resection is necessary [31].
Therefore, the detection and management of LCLNM is
necessary to improve the treatment outcome in MPTC.
US findings should be considered when deciding whether
to perform surgery or adjuvant therapy because US is the
best imaging technique for detecting thyroid nodules. It
can also help discriminate benign nodules from malignant
ones. Hypoechogenicity, microcalcifications, poorly de-
fined margins, and taller than wide in the transverse plane
are suspicious sonographic findings in PTC, and should
lead to a US-guided FNA being performed [9,14].
Although US is an excellent tool for detecting LCLNM
in either primary cases or recurrences [32], the clinical
implications of the US findings, such as prognosis strati-
fication or predicting aggressive tumor behavior, are not
well understood. Previously, we reported that the US
findings of PTC are related to extrathyroidal extension
and CLNM [18]. In this study, most of the tumors were
hypoechoic or markedly hypoechoic (90.9%) and ill-
defined (73.2%). The various tumor shapes were distrib-
uted evenly. Microcalcification (13.2%) was not detected
more frequently than other types of calcification, unlike in
other reports. Neither absence of calcification nor micro-
calcificaion in PTC was a risk factor for LCLNM. It is
probably caused by the relatively low detection rate of
microcalcification in MPTC in this study. Other types of
calcification, including macrocalcification and fine stippled
psammomatous calcification, can be risk factors for
LCLNM. Underestimating microcalcification and the high
proportions of other types of calcification is thought to be
associated with these results. However, the potential for
LNM varies among these hypoechoic lesions. Therefore,
we subdivided hypoechoic lesions into hypoechoic and
markedly hypoechoic tumors and this revealed differences
in tumor behavior that were significant in the univariate
analysis. Since most of LNM in PTC occurs in sequence
from the central lymph nodes to the lateral cervical lymph
nodes, a hypoechoic lesion with a higher rate of CLNM is
also likely to have a higher rate of LCLNM. Large tumor
and calcification are risk factors for LNM [33]. However
in this study, tumor size in MPTC did not affect the
rate of LNM, and the presence of calcification sub-
types other than microcalcification was a significant risk
factor for LCLNM. Although not significant, most of
LCLNMs (n = 13, 92.9%) were found in the tumor with
poorly defined margins. Considering that extrathyroidal
extension was found in 12 cases, the combined effect of
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be affect the rate of LCLNM.
Previous studies were based mainly on the diagnostic
value of metastatic lymph nodes rather than the signifi-
cance of each manifestation on US. The sensitivity and
specificity for LCLNM are about 90% and 85%, respect-
ively, and vary among different reports [34,35]. We hy-
pothesized that US findings may predict tumor behavior,
and we examined in this study whether the primary tumor
characteristics on US are related to LCLNM.
There are some limitations to this study. The diagnostic
accuracy of the US findings suggesting malignancy and
the direct relationship between the US findings and recur-
rence rate or survival rate were not evaluated because this
study had a cross-sectional design. Despite the limitations,
this study identified some pathological features of aggres-
sive primary tumors seen on US that might reflect an in-
creased rate of LCLNM. However, no evident report on
tumor biology explains this relationship.
Conclusions
The primary tumors of MPTC show differences in their
US findings. An increased risk of CLNM was reflected
mostly in hypoechogenicity or marked hypoechogenicity
on US findings for the primary tumor. Despite its low
incidence, the risk of LCLNM is significantly related to
marked hypoechogenicity and some types of calcifica-
tion. Markedly hypoechoic lesions might be an indicator
of tumor aggressiveness. Further study of tumor biology
is needed to explain the correlation between the US
findings and pathology.
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